These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22668950)

  • 1. Remote sensing of HIV care programmes using centrally collected laboratory results: can we monitor ART programme effectiveness?
    Morrow C; Munro A; Wilke M; Stark R; Wood R
    S Afr Med J; 2012 Mar; 102(6):501-5. PubMed ID: 22668950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial.
    Mermin J; Ekwaru JP; Were W; Degerman R; Bunnell R; Kaharuza F; Downing R; Coutinho A; Solberg P; Alexander LN; Tappero J; Campbell J; Moore DM
    BMJ; 2011 Nov; 343():d6792. PubMed ID: 22074711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study.
    Salazar-Vizcaya L; Keiser O; Karl Technau ; Davies MA; Haas AD; Blaser N; Cox V; Eley B; Rabie H; Moultrie H; Giddy J; Wood R; Egger M; Estill J
    AIDS; 2014 Oct; 28(16):2451-60. PubMed ID: 25392857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study.
    Kahn JG; Marseille E; Moore D; Bunnell R; Were W; Degerman R; Tappero JW; Ekwaru P; Kaharuza F; Mermin J
    BMJ; 2011 Nov; 343():d6884. PubMed ID: 22074713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective long-term outcomes of a cohort of Ugandan children with laboratory monitoring during antiretroviral therapy.
    Kekitiinwa A; Asiimwe AR; Kasirye P; Korutaro V; Kitaka S; Maganda A; Madalon M; Graziano FM
    Pediatr Infect Dis J; 2012 Aug; 31(8):e117-25. PubMed ID: 22581223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.
    Lowrance D; Filler S; Makombe S; Harries A; Aberle-Grasse J; Hochgesang M; Libamba E
    Trop Med Int Health; 2007 Mar; 12(3):377-81. PubMed ID: 17313509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the completeness and accuracy of South African National Laboratory CD4 and viral load data: a cross-sectional study.
    Bassett IV; Huang M; Cloete C; Candy S; Giddy J; Frank SC; Parker RA
    BMJ Open; 2018 Aug; 8(8):e021506. PubMed ID: 30139898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell phone-based and internet-based monitoring and evaluation of the National Antiretroviral Treatment Program during rapid scale-up in Rwanda: TRACnet, 2004-2010.
    Nsanzimana S; Ruton H; Lowrance DW; Cishahayo S; Nyemazi JP; Muhayimpundu R; Karema C; Raghunathan PL; Binagwaho A; Riedel DJ
    J Acquir Immune Defic Syndr; 2012 Feb; 59(2):e17-23. PubMed ID: 22067668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
    Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
    MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007.
    Cornell M; Grimsrud A; Fairall L; Fox MP; van Cutsem G; Giddy J; Wood R; Prozesky H; Mohapi L; Graber C; Egger M; Boulle A; Myer L;
    AIDS; 2010 Sep; 24(14):2263-70. PubMed ID: 20683318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementation.
    Wouters E; Heunis C; Ponnet K; Van Loon F; Booysen Fle R; van Rensburg D; Meulemans H
    BMC Public Health; 2010 Jul; 10():387. PubMed ID: 20594326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in absolute CD4 count with antiretroviral treatment in resource limited setting: a retrospective cohort study in children in Ethiopia.
    Berhan Y
    Ethiop Med J; 2011 Oct; 49(4):289-98. PubMed ID: 23409394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study.
    Kaplan SR; Oosthuizen C; Stinson K; Little F; Euvrard J; Schomaker M; Osler M; Hilderbrand K; Boulle A; Meintjes G
    PLoS Med; 2017 Nov; 14(11):e1002407. PubMed ID: 29112692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
    Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP;
    Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.
    Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration
    Lancet HIV; 2019 Feb; 6(2):e105-e115. PubMed ID: 30723008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
    Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
    J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of dried blood spots for HIV viral load monitoring in decentralized area in North Vietnam in a test-and-treat era, the MOVIDA project.
    Nguyen TA; Tran TH; Nguyen BT; Pham TTP; Hong Le NT; Ta DV; Phan HTT; Nguyen LH; Ait-Ahmed M; Ho HT; Taieb F; Madec Y;
    PLoS One; 2020; 15(4):e0230968. PubMed ID: 32271796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China.
    Shen Z; Zhu Q; Tang Z; Pan SW; Zhang H; Jiang H; Chen Y; Lan G; Xing H; Liao L; Feng Y; Ruan Y; Shao Y
    Clin Infect Dis; 2016 Jul; 63(1):108-14. PubMed ID: 27001800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy, CD4, viral load, and disease stage in HIV patients in Saudi Arabia: a 2001-2013 cross-sectional study.
    Memish ZA; Al-Tawfiq JA; Filemban SM; Qutb S; Fodail A; Ali B; Darweeish M
    J Infect Dev Ctries; 2015 Jul; 9(7):765-9. PubMed ID: 26230128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.